228 related articles for article (PubMed ID: 1700329)
1. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
Reid MS; Herrera-Marschitz M; Hökfelt T; Ohlin M; Valentino KL; Ungerstedt U
Neuroscience; 1990; 36(3):643-58. PubMed ID: 1700329
[TBL] [Abstract][Full Text] [Related]
2. Effects of intranigral substance P and neurokinin A on striatal dopamine release--II. Interactions with bicuculline and naloxone.
Reid MS; Herrera-Marschitz M; Ungerstedt U
Neuroscience; 1990; 36(3):659-67. PubMed ID: 1700330
[TBL] [Abstract][Full Text] [Related]
3. Intranigral substance P stimulation of striatal dopamine release is inhibited by spantide II: a new tachykinin antagonist without apparent neurotoxicity.
Reid MS; Hökfelt T; Herrera-Marschitz M; Håkanson R; Feng DM; Folkers K; Goldstein M; Ungerstedt U
Brain Res; 1990 Nov; 532(1-2):175-81. PubMed ID: 1704289
[TBL] [Abstract][Full Text] [Related]
4. Intranigral substance P modulation of striatal dopamine: interaction with N-terminal and C-terminal substance P fragments.
Reid MS; Herrera-Marschitz M; Terenius L; Ungerstedt U
Brain Res; 1990 Sep; 526(2):228-34. PubMed ID: 1701682
[TBL] [Abstract][Full Text] [Related]
5. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms.
Reid MS; Herrera-Marschitz M; Hökfelt T; Lindefors N; Persson H; Ungerstedt U
Exp Brain Res; 1990; 82(2):293-303. PubMed ID: 1704847
[TBL] [Abstract][Full Text] [Related]
6. Striatal dopamine and glutamate release: effects of intranigral injections of substance P.
Reid MS; Herrera-Marschitz M; Kehr J; Ungerstedt U
Acta Physiol Scand; 1990 Dec; 140(4):527-37. PubMed ID: 1707211
[TBL] [Abstract][Full Text] [Related]
7. Effects of intranigral substance P and neurokinin A injections on extracellular dopamine levels measured with microdialysis in the striatum and frontoparietal cortex of rats.
Reid MS; Herrera-Marschitz M; Ungerstedt U
J Neurochem; 1991 Sep; 57(3):970-4. PubMed ID: 1713616
[TBL] [Abstract][Full Text] [Related]
8. Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P.
Reid M; Herrera-Marschitz M; Hökfelt T; Terenius L; Ungerstedt U
Eur J Pharmacol; 1988 Mar; 147(3):411-20. PubMed ID: 2454197
[TBL] [Abstract][Full Text] [Related]
9. Interaction of substance P antagonists with substance P receptors on dispersed pancreatic acini.
Jensen RT; Jones SW; Lu YA; Xu JC; Folkers K; Gardner JD
Biochim Biophys Acta; 1984 Jun; 804(2):181-91. PubMed ID: 6202326
[TBL] [Abstract][Full Text] [Related]
10. Blockade of slow excitatory post-synaptic potential by substance P antagonists in guinea-pig sympathetic ganglia.
Konishi S; Otsuka M
J Physiol; 1985 Apr; 361():115-30. PubMed ID: 2580973
[TBL] [Abstract][Full Text] [Related]
11. Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons.
Baruch P; Artaud F; Godeheu G; Barbeito L; Glowinski J; Chéramy A
Neuroscience; 1988 Jun; 25(3):889-98. PubMed ID: 2457187
[TBL] [Abstract][Full Text] [Related]
12. Effects of the substance P antagonist, (D-Arg1, D-Pro2, D-Trp7,9, Leu11)-SP on the miotic response to substance P, antidromic trigeminal nerve stimulation, capsaicin, prostaglandin E1, compound 48/80 and histamine.
Mandahl A; Bill A
Acta Physiol Scand; 1984 Jan; 120(1):27-35. PubMed ID: 6202097
[TBL] [Abstract][Full Text] [Related]
13. Intranigral injection of selective neurokinin-1 and neurokinin-3 but not neurokinin-2 receptor agonists biphasically modulate striatal dopamine metabolism but not striatal preprotachykinin-A mRNA in the rat.
Humpel C; Saria A
Neurosci Lett; 1993 Jul; 157(2):223-6. PubMed ID: 7694197
[TBL] [Abstract][Full Text] [Related]
14. Interaction of a substance P agonist and of substance P antagonists with lipid membranes. A thermodynamic analysis.
Seelig A
Biochemistry; 1992 Mar; 31(11):2897-904. PubMed ID: 1372515
[TBL] [Abstract][Full Text] [Related]
15. Solution conformation of Substance P antagonists-[D-Arg1, D-Trp7,9, Leu11]-SP, [D-Arg1, D-Pro2, D-Trp7,9, Leu11]-SP and [D-Pro2, D-Trp7,9]-SP by CD, NMR and MD simulations.
Prabhu A; Malde A; Coutinho E; Srivastava S
Peptides; 2005 May; 26(5):875-85. PubMed ID: 15808918
[TBL] [Abstract][Full Text] [Related]
16. [Effects of GABA and substance P on metabolism of striatal dopamine following experimental cerebral ischemia].
Li QY
Zhonghua Yi Xue Za Zhi; 1993 Nov; 73(11):677-9, 702. PubMed ID: 7510213
[TBL] [Abstract][Full Text] [Related]
17. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.
Reid MS; O'Connor WT; Herrera-Marschitz M; Ungerstedt U
Brain Res; 1990 Jun; 519(1-2):255-60. PubMed ID: 1975763
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of spinal cord substance P: studies with a stable receptor agonist.
Keeler JR; Charlton CG; Helke CJ
J Pharmacol Exp Ther; 1985 Jun; 233(3):755-60. PubMed ID: 2409270
[TBL] [Abstract][Full Text] [Related]
19. Studies on effects of the substance P analogues [D-Pro2, D-Trp7,9]-substance P and [D-Arg1, D-Trp7,9, L-Leu11]-substance P not related to their antagonist action.
Lembeck F; Amann R; Barthó L
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):290-3. PubMed ID: 2429194
[TBL] [Abstract][Full Text] [Related]
20. Intranigral application of substance P antagonists prevents the haloperidol-induced activation of striatal tyrosine hydroxylase.
Melis MR; Gale K
Naunyn Schmiedebergs Arch Pharmacol; 1984 May; 326(1):83-6. PubMed ID: 6206401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
